in vitro News and Research

RSS
Capability of BNT162b2 vaccine given in 2 or 3 doses to neutralize SARS-CoV-2 Omicron

Capability of BNT162b2 vaccine given in 2 or 3 doses to neutralize SARS-CoV-2 Omicron

Experimental and computational synergy considered a promising approach in COVID-19 patients

Experimental and computational synergy considered a promising approach in COVID-19 patients

Human monoclonal antibody protects against SARS-CoV-2 and SARS-CoV in vivo

Human monoclonal antibody protects against SARS-CoV-2 and SARS-CoV in vivo

Study suggests Omicron can be neutralized by BNT162b2 recipient sera optimally after three vaccine doses

Study suggests Omicron can be neutralized by BNT162b2 recipient sera optimally after three vaccine doses

T-cell immune response in previously infected and vaccinated individuals effective against SARS-CoV-2 Omicron variant

T-cell immune response in previously infected and vaccinated individuals effective against SARS-CoV-2 Omicron variant

BrainGlobe; An Open-Source Platform for Neuroscientists

BrainGlobe; An Open-Source Platform for Neuroscientists

Engineering of brain-mimetic injectable hydrogel scaffolds with self-healing properties

Engineering of brain-mimetic injectable hydrogel scaffolds with self-healing properties

Providing quick & efficient CRO services with Sino Biological

Providing quick & efficient CRO services with Sino Biological

Evaluating the virucidal activity of blue LED light against SARS-CoV-2 infection

Evaluating the virucidal activity of blue LED light against SARS-CoV-2 infection

Researchers develop a universal SARS-CoV-2 neutralizing antibody

Researchers develop a universal SARS-CoV-2 neutralizing antibody

Genetic-code expansion technique to potentially create next-generation vaccine candidate

Genetic-code expansion technique to potentially create next-generation vaccine candidate

Effect of mutations on SARS-CoV-2 E protein interactions with cell junctions

Effect of mutations on SARS-CoV-2 E protein interactions with cell junctions

Even if SARS-CoV-2 Omicron evades antibodies, immunity still exists

Even if SARS-CoV-2 Omicron evades antibodies, immunity still exists

Vaccinated, previously-infected people could have some "stronger than basic" defense against Omicron variant

Vaccinated, previously-infected people could have some "stronger than basic" defense against Omicron variant

Screening FDA-approved compounds shown to possess antiviral or antimicrobial activity for SARS-CoV-2 inhibition

Screening FDA-approved compounds shown to possess antiviral or antimicrobial activity for SARS-CoV-2 inhibition

Characterization of SARS-CoV-2 spike protein mutation with no associated increase in epidemiological fitness

Characterization of SARS-CoV-2 spike protein mutation with no associated increase in epidemiological fitness

Study reveals the role of intracellular receptor PQBP1 in response to Tau protein

Study reveals the role of intracellular receptor PQBP1 in response to Tau protein

Effect of SARS-CoV-2 variant emergence on efficacy of neutralizing antibodies and vaccines

Effect of SARS-CoV-2 variant emergence on efficacy of neutralizing antibodies and vaccines

Potential association between senescence and aging in COVID-19

Potential association between senescence and aging in COVID-19

Study identifies ORF8 protein as a key COVID-19 causing factor

Study identifies ORF8 protein as a key COVID-19 causing factor